Lipid Insights

National Lipid Association
  • 0.0(0개의 평가)
  • 의학
  • 격월 업데이트

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to stay at the forefront of lipidology!

  1. 1일 전

    Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That's Changing Everything

    Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is changing rapidly. In this Industry Innovations episode, guest host Kevin Maki, PhD, CLS, MNLA sits down with Archna Bajaj, MD, FNLA for a comprehensive and forward-looking conversation on FCS from every angle. Dr. Bajaj walks through the realities of living with FCS — from diagnosis to the demands of a strict ultra-low-fat diet — before turning to what has the field buzzing: two landmark APOC3-targeting therapies and the clinical trial data behind them. A must-listen for any clinician caring for patients with rare lipid disorders, and a glimpse at a future where FCS management looks fundamentally different. This episode's topic comes courtesy of Arrowhead Pharmaceuticals, Inc. a member of the NLA Industry Council. Watch this episode on YouTube HERE.

    Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That's Changing Everything

  2. 8월 12일

    S7E9: HDL Under the Microscope: Setting the Record Straight with Dr. Lipid

    In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "Dr. Lipid" — for a deep dive into one of lipidology's most complex and frequently misrepresented topics: HDL-Cholesterol. From the history of HDL and how our understanding of it has evolved over decades, to a true microscope-level look at HDL biochemistry and functionality, Dr. Dayspring does what he does best: peeling back the layers to reveal what HDL is really telling us and what it isn't. Follow @drlipid on X (Twitter) and LinkedIn.

  3. 7월 1일

    S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention

    How do we move the needle on cardiovascular prevention — not just in the clinic, but across entire systems and communities? In this episode of Lipid Insights, host Alan S. Brown, MD, MHA, MNLA sits down with Nihar R. Desai, MD, MPH, FNLA for a forward-thinking conversation on long-term LDL exposure and what it truly means to practice longevity medicine. From the power of imaging as a patient education tool to the momentum behind the 2026 dyslipidemia guidelines, Dr. Desai shares his vision for a healthcare landscape where patients are empowered, systems are hardwired to deliver better care, and public education closes the gap between what we know and what gets done. A timely and thought-provoking listen for any clinician committed to moving cardiovascular prevention forward.

  4. 5월 10일

    S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know

    What does your patient's lipid panel actually tell you and what is it missing? In this special National Lipid Day episode of Lipid Insights, host Peter H. Jones, MD, MNLA, sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "The Lipid Doctor" — for a conversation that challenges some of medicine's most entrenched assumptions about lipid risk assessment. From the clinical superiority of ApoB over LDL-C and the underrecognized atherogenic burden of Lipoprotein(a), to why HDL-C should no longer be treated as a therapeutic target, Dr. Dayspring delivers evidence-based truths that have direct implications for how clinicians assess and manage cardiovascular risk. If you order lipid panels, counsel patients on cholesterol, or manage ASCVD risk in any capacity — this episode is essential listening. Follow @drlipid on X (Twitter) and LinkedIn. https://x.com/Drlipid https://www.linkedin.com/in/thomas-dayspring-md-facp-fnla-3aaa876/

  5. 4월 16일

    S7E6: Identification of Rare Lipid Disorders in Children

    In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Nivedita Patni, MD, of the Department of Pediatrics at UT Southwestern Medical Center in Dallas, TX, to explore the complex landscape of pediatric dyslipidemia. Dr. Patni walks through the critical importance of tailoring management to etiology, the long-term cardiovascular and metabolic risks that hang in the balance, and why early identification is everything. Drawing on case studies and evidence-based management strategies, Dr. Patni shares practical implementation guidelines for clinicians navigating these challenging diagnoses — including the challenges that make rare lipid disorders in children so easy to overlook and so difficult to treat. She also highlights the essential role of multidisciplinary care, bringing together endocrinology, dietetics, and family support to deliver truly individualized treatment. Whether you're seeing these patients regularly or encountering them for the first time, this episode will sharpen your clinical lens and equip you with actionable strategies to make a difference early.

  6. 4월 3일

    S7E5: Tackling Childhood Obesity: Innovative Strategies for a Healthier Future

    Childhood obesity is one of the most pressing public health challenges of our time — and its long-term cardiovascular and metabolic consequences make it essential territory for lipidologists and clinicians alike. In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Casey Berman, MD to explore the full picture: how childhood obesity is defined, why its prevalence continues to rise, and the behavioral, societal, and genetic factors fueling the epidemic. They also dive into associated comorbidities and the latest prevention and management strategies — from lifestyle modifications and pharmacotherapy to the evolving role of bariatric and metabolic surgery. A must-listen for any clinician looking to better support their youngest patients.

  7. 3월 17일

    S7E4: 2026 ACC/AHA Cholesterol (Dyslipidemia) Guidelines: Clinical Meaning for Lipidologists

    Join host Dr. Peter H. Jones for a special episode of Lipid Insights discussing the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Dr. Jones is joined by guideline author and NLA Past President Dr. Joseph Saseen and NLA President-Elect Dr. Dinesh Kalra to break down what clinicians need to know. From the restoration of LDL-C treatment goals and major conceptual shifts from the 2018 guideline, to primordial and primary prevention, risk assessment, special populations, and real-world implementation challenges, this episode covers it all. The panel also explores the guideline's expanded scope beyond LDL-C to include triglycerides, Lp(a), ApoB, and more. This is a must-listen episode for anyone involved in dyslipidemia management. Read the Guidelines here: https://www.jacc.org/doi/10.1016/j.jacc.2025.11.016

  8. 3월 5일

    S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis

    In this episode of Lipid Insights, we explore the NLA's recent expert meta-analysis, "Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials."   Lead author Dinesh K. Kalra, MD, MBA and key author Kevin C. Maki, PhD, CLS, MNLA join host Alan S. Brown, MD, MHA, MNLA to examine the relationship between LDL-C reduction and major adverse cardiovascular events in primary prevention trials. Together, they break down the findings, clinical implications, and why early LDL-C lowering remains central to preventing first cardiovascular events. Read the meta-analysis: https://www.lipidjournal.com/article/S1933-2874(26)00039-5/fulltext

모두 보기(45개)

소개

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to stay at the forefront of lipidology!

정보

  • 제작진
    National Lipid Association
  • 방송 연도
    2020년 - 2026년
  • 에피소드
    45
  • 등급
    전체 연령 사용가
  • 저작권
    © 2026 National Lipid Association
  • 웹사이트 보기
    Lipid Insights

좋아할 만한 다른 항목